The University of Queensland’s Institute for Molecular Bioscience (IMB) is a leading global life sciences research institute committed to improving quality of life through research. IMB was established in 2000 as UQ’s first research institute and is the cornerstone of one of the largest bioscience research precincts in Australia.
The successful appointee/s (one to two positions) will work with data dumps from Medicare and from the Pharmaceutical Benefits Scheme to extract, analyse and interpret the data. Our focus is primarily psychiatric disorders, in particular comorbidities, drug use and longitudinal trajectories.
Level A postdoctoral staff will be required to work with lead researchers on existing projects, whilst level B postdoctoral staff will be expected to develop and run their own research program in collaboration with members of the Program.
Applications close 6 November 2016.